The Indonesian Food and Drug Authority (; BPOM) is a government agency of Indonesia responsible for protecting public health through the control and supervision of prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, dietary supplements, food safety, traditional medicine and cosmetics. Its role is similar to that of the United States Food and Drug Administration.
BPOM is a non-ministerial government agency that carries out government duties in the field of drug and food control. It is under and directly responsible to the president, and coordinates with the minister responsible for health affairs. Since 2017, BPOM has been regulated by Presidential Decree No. 80/2017.
The predecessor of BPOM was formed during the colonial period and was named (DVG). Operating under the auspices of the Dutch pharmaceutical company, DVG itself was in charge of producing chemical drugs as well as operating a pharmaceutical research center. In 1964, during the Guided Democracy era, DVG was nationalized and became the Pharmacy Inspectorate () of the Indonesian Ministry of Health. Three years later, it was renamed the Inspectorate of Pharmaceutical Affairs (). In 1976, it was again renamed the Directorate General Drug and Food Control (, Ditjen POM).
In accordance with Presidential Decree No. 166/2000, the Directorate-General of Drug and Food Control was officially divested from the Ministry of Health to become an independent agency which reports directly to the president, though it continues to coordinate with the Ministry. Since 2017, BPOM has been regulated by Presidential Decree No. 80/2017.
BPOM was subsequently established as a Non-ministerial government body to carry out government functions in the supervision of drugs and food, as part of efforts to protect consumer rights and public health. Under this framework, BPOM was given authority over drugs and food circulating in Indonesia, including products manufactured domestically and those imported from abroad. BPOM's supervision includes sampling, testing, and laboratory analysis of food and beverages to identify hazardous substances, as well as monitoring compliance with safety, quality, and labeling requirements. This supervision is carried out across pre-market and post-market stages, supported by enforcement actions and public participation.
Institutionally, BPOM is directly responsible to the president and coordinates with the minister responsible for health affairs. Operationally, BPOM carries out its duties through a system of technical units, including , , and .
Since 2017, BPOM has been regulated by Presidential Decree No. 80/2017, which strengthened its institutional position and authority in drug and food supervision and emphasized its strategic national role in protecting public health.
In 2020, the head of BPOM issued a decree standardizing the official English-language name of the agency. The agency was previously known in English as the National Agency for Drug and Food Control.
In late 2025, BPOM received recognition from the World Health Organization as a WHO Listed Authority (WLA), which marked international recognition of Indonesia's drug and food regulatory system.
As stipulated in article 2 of Presidential Decree No. 80/2017, BPOM was tasked to execute government role in the field of drug and food control.
According to article 3 of Presidential Decree No. 80/2017, BPOM has the following functions:
Based on article 5 of Presidential Decree No. 80/2017, and as expanded by BPOM Decrees No. 21/2020 and 13/2022, BPOM is organized into the following:
BPOM has four centers, those are:
BPOM maintains regional offices across Indonesia. These consist of: